Registry of Lobbyists

Registration - In-house Organization

BIOTECANADA / ANDREW CASEY, President & CEO

Registration Information

In-house Organization name: BIOTECANADA
Responsible Officer Name: ANDREW CASEY, President & CEO 
Responsible Officer Change History
Initial registration start date: 2005-04-05
Registration status: Active
Registration Number: 836594-354

Associated Communications

Total Number of Communication Reports: 342

Monthly communication reports in the last 6 months: 10

Version 7 of 35 (2008-02-25 to 2008-07-17)

Version 7 of 35 (2008-02-25 to 2008-07-17) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Organization Information

Organization: BIOTECANADA
420 - 130 ALBERT STREET
OTTAWA, ON  K1P 5G4
Canada
Telephone number: 613-230-5585
Fax number: 613-563-8850  
Responsible officer name and position during the period of this registration: PETER BRENDERS, PRESIDENT & CEO  
 
Description of the organization's activities: BIOTECANADA IS A NOT-FOR-PROFIT ORGANIZATION THAT IS THE VOICE FOR BIOTECHNOLOGY IN CANADA. BIOTECANADA IS DEDICATED TO THE SUSTAINABLE COMMERCIAL DEVELOPMENT OF BIOTECHNOLOGY IN CANADA. IT FOCUSES ON THE ISSUES AND ACTIVITIES AFFECTING THE CANADIAN BIOTECHNOLOGY COMMUNITY, BOTH NATIONALLY AND INTERNATIONALLY. BIOTECANADA IS INVOLVED IN MANY INITIATIVES TO ADDRESS THESE ISSUES, INCLUDING REGULATORY AND POLICY ADVOCACY, FINANCE, AND THE COLLECTION AND DISSEMINATION OF MARKET INFORMATION. BIOTECANADA, IN PARTNERSHIP WITH THE REGIONAL BIOTECHNOLOGY ASSOCIATIONS, REPRESENTS 90 PERCENT OF THE CANADIAN BIOTECHNOLOGY COMMUNITY
Organization's membership or classes of membership: BIOTECANADA CURRENTLY HAS OVER 200 MEMBERS. THE MEMBERSHIP IS COMPRISED OF COMPANIES IN THE HUMAN HEALTH CARE, AGRICULTURAL, INDUSTRIAL, ENVIRONMENTAL AND SERVICE SECTORS AS WELL AS ASSOCIATIONS AND UNIVERSITIES. THE MEMBERSHIP CATEGORIES ARE: 1. BIOTECHNOLOGY INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH COMMERCIALIZE BIOTECHNOLOGY-DERIVED PRODUCTS AND/OR ARE ACTIVE IN BIOTECHNOLOGY RELATED R&D. 2. SERVICE INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH ARE CHARTERED BANKS OR THEIR SUBSIDIARIES; PROVIDE FINANCIAL, LEGAL, INSURANCE, CONSULTING OR OTHER SERVICES; OR PROVIDE SUPPLIES OR EQUIPMENT. 3. NOT-FOR-PROFIT: REGIONAL/SECTORAL ASSOCIATIONS, ACADEMIC ORGANIZATIONS AND PROFESSIONAL ASSOCIATIONS, GOVERNMENT DEPARTMENTS AND AGENCIES WITH A SCIENCE AND TECHNOLOGY MANDATE, OR FOREIGN ORGANIZATIONS
 
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Organization

Name: Betsy Bascom
Position title: VP, Business Development
Public offices held: No
 
Name: Graeme Fraser
Position title: Manager, Health Policy
Public offices held: No
 
Name: CATE MCCREADY
Position title: VP, EXTERNAL AFFAIRS
Public offices held: Yes
 
Name: Philip Schwab
Position title: VP, Industry Affairs
Public offices held: No
 
Name: Amy Suthren
Position title: Policy Analyst
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Agriculture and Agri-Food Canada (AAFC), Atlantic Canada Opportunities Agency (ACOA), Canadian International Development Agency (CIDA), CDN FOOD INSPECTION AGENCY, CIHR, Citizenship and Immigration Canada, Environment Canada, Finance Canada (FIN), Fisheries and Oceans Canada (DFO), Foreign Affairs and International Trade Canada (DFAITC), GENOME CANADA, Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, Members of the House of Commons, National Research Council (NRC), Natural Resources Canada (NRCan), Natural Sciences and Engineering Research Council (NSERC), Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Procurement Review Board of Canada (PRB), Public Works and Government Services Canada, Revenue Canada (RC), Social Sciences and Humanities Research Council (SSHRC), Statistics Canada (StatCan), Technology Partnerships Canada (TPC), Treasury Board Of Canada Secretariat (TBS)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Agriculture, BIOTECHNOLOGY, Consumer Issues, Employment and Training, Energy, Environment, Fisheries, Forestry, Government Procurement, Health, Immigration, Industry, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance
 
Subject Matter: Retrospective: INTELLECTUAL PROPERTY POLICY FOR BIOTECHNOLOGY INCLUDING DATA PROTECTION; PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB) PRICE REVIEW ISSUES; REGULATORY EFFICIENCIES INCLUDING Cost recovery initiative, REVIEW TIMES, orphan product strategy; PROGRESSIVE LICENSING FRAMEWORK; NATIONAL PHARMACEUTICAL STRATEGY; WORLD TRADE ORGANIZATION (WTO) ISSUES: Access & benefit sharing, TRIPS AGREEMENT, DISPUTE RESOLUTION; CANADIAN ENVIRONMENT PROTECTION ACT AND REGULATIONS; FOOD AND DRUGS ACT AND REGULATIONS; SUBMISSION REVIEW PROCESS FOR BIOLOGICS; FOOD LABELLING; SCIENTIFIC RESEARCH & EXPERIMENTAL DEVELOPMENT (SR&ED) TAX CREDIT PROGRAM; TAX REVIEW OF LIMITED LIABILITY CORPORATIONS; Science & technology strategy; National Biotechnology week awareness campaign with parliamentarians
Subject Matter: Prospective: NATIONAL BIOTECH WEEK; BIOTECH AWARENESS (CAUCUS) EFFORTS OF PARLIAMENTARIANS; IMPROVED TAXATION FRAMEWORK for SR&ED; REGULATORY IMPROVEMENTS including establishing a clear regulated pathway for subsequent entry biologics; ORPHAN PRODUCT POLICIES; CANADIAN science & technology STRATEGY / INNOVATION AGENDA; INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS; PMPRB PRICE REVIEW ISSUES; WTO ISSUES, ACCESS & BENEFIT SHARING: TRIPS AGREEMENT; CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS; HEALTH CANADA: FOOD AND DRUGS ACT AND REGULATIONS, SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW; REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS; SR&ED TAX CREDIT PROGRAM; BIOSAFETY PROTOCOL; ADVENTITIOUS PRESCENCE POLICY; ACCOUNTABILITY FOR CADTH/CDR
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program ACCESS & BENEFIT SHARING: TRIPS AGREEMENT
Policy or Program ADVENTITIOUS PRESCENCE POLICY
Policy or Program BIOSAFETY PROTOCOL
Policy or Program CANADIAN BIOTECHNOLOGY STRATEGY / INNOVATION AGENDA / SCIENCE & TECHNOLOGY STRATEGY
Bill or Resolution, Regulation CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS
Policy or Program Creation of a modern regulatory environment, recognition of international standards and reviews, and establishing clarity on data ownership for intellectual property
Policy or Program Establish accountability with the federally financed Canadian Agency for Drugs and Technologies and Health (CADTH) and its Common Drug Review process (Health Canada)
Regulation FOOD AND DRUGS ACT AND REGULATIONS
Policy or Program IMPROVED TAXATION FRAMEWORK
Policy or Program IMPROVEMENTS TO THE SR&ED TAX CREDITS
Policy or Program, Regulation INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS
Policy or Program NOVEL FOODS AND FOOD LABELLING
Policy or Program ORPHAN PRODUCT POLICIES
Policy or Program PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW
Policy or Program, Regulation REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS
Regulation, Policy or Program Regulatory framework for subsequent entry biologics
Policy or Program SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW
Policy or Program WORLD TRADE ORGANIZATION (WTO) ISSUES




Date Modified: